Methyl 5-amino-2-morpholinobenzoate

Catalog No.: 
ACLOPU132
CAS No.: 
4031-84-9
Molecular Formula: 
C12H16N2O3
Molecular Weight: 
236.27
Methyl 5-amino-2-morpholinobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$51.00In stockInquiry
1g97%$133.00In stockInquiry
5g97%$380.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-amino-2-morpholinobenzoate
IUPAC Namemethyl 5-amino-2-morpholinobenzoate
MDL No.MFCD00277666
Molecular FormulaC12H16N2O3
Molecular Weight236.27
SMILESO=C(OC)C1=CC(N)=CC=C1N2CCOCC2.[H]Cl.[H]Cl
InChI KeyUDCGGVAQNYMTAZ-UHFFFAOYSA-N
Synonym5-Amino-2-(4-morpholinyl)benzoic acid methyl ester;Methyl 5-amino-2-morpholinobenzoate;Benzoic acid, 5-amino-2-(4-morpholinyl)-, methyl ester
CAS No.4031-84-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLOPU132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUPXZ978 route compound structure diagram
    ACUPXZ97856741-34-5In Stock
  4. Then
  5. ACLOPU132 route product structure diagram
    ACLOPU1324031-84-9In Stock
Inquiry

2. ACLOPU132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLOPU132 route product structure diagram
    ACLOPU1324031-84-9In Stock
Inquiry

3. ACLOPU132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLOPU132 route product structure diagram
    ACLOPU1324031-84-9In Stock
Inquiry

Comments (0)